ArticleGeroScience2026
A Bacillus subtilis strain with high proficiency for biofilm formation delays the onset of aging-associated morphological defects in cholinergic neurons of C. elegans.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aging is accompanied by progressive functional decline and morphological defects of cholinergic neurons. Some probiotic bacteria with proficiency for biofilm formation in the gut are being discussed as potentially neuroprotective. Here, we screened Bacillus subtilis (B. subtilis) strains for biofilm production, using an in vitro assay. Thereafter, a transgenic Caenorhabditis elegans (C. elegans) strain with its cholinergic neurons expressing green fluorescent protein (GFP) was fed for up to 15 days on either the identified biofilm-producing B. subtilis strain B4U 50 or the control B. subtilis strain 168, with or without addition of a standardized Ginkgo biloba preparation. The morphology of the cholinergic neurons was monitored at several consecutive days by fluorescence microscopy. The occurrence of morphological defects such as knots and ruptures within the axons of cholinergic neurons, as observed with increasing age, was significantly lower in nematodes provided with the B4U 50 strain. Even worms whose diet was switched to B4U 50 later in life showed less damage of their neurons, as compared to worms fed on the control strain. Supplementation with the Ginkgo biloba preparation was neuroprotective in worms fed on either B. subtilis strain, while a stronger beneficial effect was observed upon combined administration of B. subtilis B4U 50 and the Ginkgo biloba preparation. In conclusion, feeding a B. subtilis strain proficient for biofilm formation, B4U 50, was neuroprotective when compared to a diet consisting of control B. subtilis, delaying the onset of aging-associated morphological defects in cholinergic neurons of C. elegans.
Indexed as
Identifiers
42886461What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.